Dare Bioscience Valuation
| DARE Stock | USD 1.71 0.00 0.00% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Dare Bioscience shows a prevailing Real Value of $3.92 per share. The current price of the firm is $1.71. Our model computes the value of Dare Bioscience from reviewing the firm fundamentals such as Shares Owned By Insiders of 8.73 %, current valuation of 4.15 M, and Shares Owned By Institutions of 8.01 % as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Dare Bioscience's valuation include:
Price Book 8.4998 | Enterprise Value | Enterprise Value Ebitda (2.06) | Price Sales 751.5095 | Enterprise Value Revenue 4.8688 |
Undervalued
Today
Please note that Dare Bioscience's price fluctuation is unstable at this time. Calculation of the real value of Dare Bioscience is based on 3 months time horizon. Increasing Dare Bioscience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Dare stock is determined by what a typical buyer is willing to pay for full or partial control of Dare Bioscience. Since Dare Bioscience is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Dare Stock. However, Dare Bioscience's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.71 | Real 3.92 | Target 10.75 | Hype 1.7 |
The real value of Dare Stock, also known as its intrinsic value, is the underlying worth of Dare Bioscience Company, which is reflected in its stock price. It is based on Dare Bioscience's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Dare Bioscience's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Dare Bioscience helps investors to forecast how Dare stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Dare Bioscience more accurately as focusing exclusively on Dare Bioscience's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Dare Bioscience's intrinsic value based on its ongoing forecasts of Dare Bioscience's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Dare Bioscience's closest peers. If more than one evaluation category is relevant for Dare Bioscience we suggest using both methods to arrive at a better estimate.
Dare Bioscience Cash |
|
Dare Bioscience Total Value Analysis
Dare Bioscience is currently projected to have valuation of 4.15 M with market capitalization of 22.92 M, debt of 1.3 M, and cash on hands of 40.39 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Dare Bioscience fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.15 M | 22.92 M | 1.3 M | 40.39 M |
Dare Bioscience Investor Information
The company recorded a loss per share of 1.83. Dare Bioscience last dividend was issued on the 20th of July 2017. The entity had 1:12 split on the 1st of July 2024. Based on the measurements of operating efficiency obtained from Dare Bioscience's historical financial statements, Dare Bioscience may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Dare Bioscience Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Dare Bioscience has an asset utilization ratio of 0.0443 percent. This indicates that the Company is making $4.43E-4 for each dollar of assets. An increasing asset utilization means that Dare Bioscience is more efficient with each dollar of assets it utilizes for everyday operations.Dare Bioscience Profitability Analysis
Based on the measurements of profitability obtained from Dare Bioscience's financial statements, Dare Bioscience may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Dare Bioscience's ability to earn profits and add value for shareholders.Net Loss | First Reported 2013-03-31 | Previous Quarter -4 M | Current Value -3.6 M | Quarterly Volatility 4.2 M |
For Dare Bioscience profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Dare Bioscience to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Dare Bioscience utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Dare Bioscience's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Dare Bioscience over time as well as its relative position and ranking within its peers.
Dare Bioscience Earnings per Share Projection vs Actual
By analyzing Dare Bioscience's earnings estimates, investors can diagnose different trends across Dare Bioscience's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Dare Bioscience is based on EPS before non-recurring items and includes expenses related to employee stock options.Dare Bioscience Ownership Allocation
The market capitalization of Dare Bioscience is $22.92 Million. Dare Bioscience shows 8.73 percent of its outstanding shares held by insiders and 8.01 percent owned by other corporate entities. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Dare Bioscience Profitability Analysis
The company reported the previous year's revenue of 9.78 K. Net Loss for the year was (4.05 M) with loss before overhead, payroll, taxes, and interest of (14.35 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Dare Bioscience's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Dare Bioscience and how it compares across the competition.
About Dare Bioscience Valuation
The stock valuation mechanism determines Dare Bioscience's current worth on a weekly basis. Our valuation model uses a comparative analysis of Dare Bioscience. We calculate exposure to Dare Bioscience's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Dare Bioscience's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -12.9 M | -12.2 M | |
| Pretax Profit Margin | (372.88) | (391.52) | |
| Operating Profit Margin | -2.8 K | -2.6 K | |
| Net Loss | (372.88) | (391.52) | |
| Gross Profit Margin | -1.7 K | -1.6 K |
Dare Bioscience Current Valuation Indicators
Valuation refers to the process of determining the present value of Dare Bioscience and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Dare we look at many different elements of the entity such as Dare's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Dare Bioscience, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Dare Bioscience's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Dare Bioscience's worth.Complementary Tools for Dare Stock analysis
When running Dare Bioscience's price analysis, check to measure Dare Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dare Bioscience is operating at the current time. Most of Dare Bioscience's value examination focuses on studying past and present price action to predict the probability of Dare Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dare Bioscience's price. Additionally, you may evaluate how the addition of Dare Bioscience to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |